Drugs / Ketone Monoester
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 01 trial | ||||||
| Phase 0 | NCT06108076 | Jan 2024 → Jul 2026 overdue | heart failure, type 2 diabetes mellitus | The University of Texas Health Science Center at San Antonio | Recruiting | No outcome recorded |
| Phase 21 trial | ||||||
| Phase 2 | NCT07364162 | Jun → Dec 2026 expected | delirium | Vanderbilt University Medical Center | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Ketone monoester | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07364162 ↗ |
| Route | Oral | “subject will take two separate doses of oral ketones” NCT06108076 ↗ |